LISPRO WITH INSULIN IN MANAGEMENT OF CHILD WITH INSULIN DEPENDENT DIABETES

赖脯氨酸已在成人糖尿病患者中进行了研究，并证明是安全的。 众所周知，赖脯胰岛素起效快，起效快，且持续时间不如优泌林常规胰岛素。 尚未在儿童中研究起效时间和作用持续时间。 Lispro更方便服用，因为它可以在更接近用餐时服用。 然而，它可能不会持续足够长的时间来提供血糖覆盖超过2-3小时后，它是给。 因此，赖脯胰岛素可能无法为儿童典型的餐间零食提供足够的胰岛素。 为了确定哪种速效胰岛素能更好地控制儿童的血糖，需要在给予每种类型的胰岛素后进行频繁血糖监测的比较。

Lispro has been studied in adult patients with diabetes and shown to be safe. It is known that lispro starts working faster, has its maximal effects sooner, and does not last as long as humulin regular insulin. The onset of effect and duration of action has not been studies yet in children. Lispro is more convenient to take as it may be given closer to meals. However, it may not last long enough to provide blood sugar coverage for more than 2-3 hours after it is given. Therefore, lispro may not provide adequate insulin coverage for the between meal snacks tht are typical of a child's diet. In order to determine which rapid acting insulin provides better blood sugar control in children, a comparison of frequent blood sugar monitoring after each type of insulin is given needs to be done.